Skip to content

Avanos Medical AVNS Enterprise value

Enterprise value at other companies

Stryker logo
StrykerSYK
$137.35B-12.4%
Cardinal Health logo
Cardinal HealthCAH
$54.7B+45.4%
Boston Scientific logo
Boston ScientificBSX
$141.04B-1.0%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$1.18B-3.4%
Medtronic logo
MedtronicMDT
$131.22B-3.2%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$765.76M-9.8%

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B-1.2%
P/S1.6×-0.1×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Calculated from Avanos Medical’s reported figures.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's enterprise value?
Avanos Medical (AVNS) reported enterprise value of $724.37M in Q1 2026.
How has Avanos Medical's enterprise value changed year-over-year?
Avanos Medical's enterprise value increased by 3.0% year-over-year, from $703.13M to $724.37M.
What is the long-term trend for Avanos Medical's enterprise value?
Over 5 years (2020 to 2025), Avanos Medical's enterprise value has grown at a -24.9% compound annual growth rate (CAGR), from $2.35B to $560.58M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.